341,499 Shares in The Ensign Group, Inc. $ENSG Bought by Paradigm Capital Management Inc. NY

Posted by Brian Himes on Aug 25th, 2026

Paradigm Capital Management Inc. NY bought a new stake in The Ensign Group, Inc. (NASDAQ:ENSG – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 341,499 shares of the company’s stock, valued at approximately $54,742,000. The Ensign Group comprises about 1.5% of Paradigm Capital Management Inc. NY’s portfolio, making the stock its 15th biggest position. Paradigm Capital Management Inc. NY owned 0.59% of The Ensign Group as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the company. Mitsubishi UFJ Trust & Banking Corp lifted its position in The Ensign Group by 52.5% in the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 54,336 shares of the company’s stock worth $9,465,000 after buying an additional 18,699 shares during the last quarter. Sanctuary Advisors LLC grew its position in The Ensign Group by 594.9% during the fourth quarter. Sanctuary Advisors LLC now owns 24,510 shares of the company’s stock valued at $4,270,000 after acquiring an additional 20,983 shares during the last quarter. NewEdge Wealth LLC purchased a new position in shares of The Ensign Group during the fourth quarter worth approximately $5,224,000. Norges Bank purchased a new position in shares of The Ensign Group during the fourth quarter worth approximately $134,660,000. Finally, Dockside LLC bought a new stake in shares of The Ensign Group in the 2nd quarter worth approximately $2,180,000. Hedge funds and other institutional investors own 96.12% of the company’s stock.

Insiders Place Their Bets

In other The Ensign Group news, Director John O. Agwunobi sold 392 shares of the company’s stock in a transaction on Monday, July 20th. The shares were sold at an average price of $171.06, for a total value of $67,055.52. Following the completion of the transaction, the director directly owned 9,503 shares in the company, valued at approximately $1,625,583.18. This represents a 3.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Barry M. Smith sold 700 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total transaction of $114,996.00. Following the completion of the sale, the director directly owned 21,352 shares of the company’s stock, valued at approximately $3,507,706.56. This represents a 3.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.00% of the stock is currently owned by insiders.

The Ensign Group Trading Down 0.1%

ENSG opened at $179.37 on Tuesday. The Ensign Group, Inc. has a one year low of $141.58 and a one year high of $218.00. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.21 and a quick ratio of 1.21. The business has a 50 day simple moving average of $171.68 and a two-hundred day simple moving average of $184.54. The firm has a market capitalization of $10.45 billion, a price-to-earnings ratio of 28.11, a PEG ratio of 1.73 and a beta of 0.68.

The Ensign Group (NASDAQ:ENSG – Get Free Report) last issued its quarterly earnings data on Monday, July 27th. The company reported $1.92 earnings per share for the quarter, topping analysts’ consensus estimates of $1.80 by $0.12. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%.The firm had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.44 billion. During the same period last year, the company earned $1.59 EPS. The business’s quarterly revenue was up 16.7% compared to the same quarter last year. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Analysts predict that The Ensign Group, Inc. will post 6.93 EPS for the current year.

The Ensign Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th were given a dividend of $0.065 per share. This represents a $0.26 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date of this dividend was Tuesday, June 30th. The Ensign Group’s payout ratio is presently 4.08%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. Wall Street Zen cut shares of The Ensign Group from a “buy” rating to a “hold” rating in a research report on Saturday, July 25th. Royal Bank Of Canada restated an “outperform” rating and issued a $228.00 target price on shares of The Ensign Group in a report on Tuesday, July 28th. Truist Financial upped their price target on shares of The Ensign Group from $202.00 to $207.00 and gave the company a “hold” rating in a report on Thursday, July 30th. Finally, Weiss Ratings lowered shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, June 16th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, The Ensign Group presently has an average rating of “Moderate Buy” and a consensus target price of $216.25.

Get Our Latest Research Report on The Ensign Group

The Ensign Group Profile

(Free Report)

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.